首頁 > 市場調查報告書 > 製藥

中東和非洲腸外營養市場預測至 2030 年 - 區域分析 - 按營養類型和最終用戶

市場調查報告書

商品編碼

1562389

中東和非洲腸外營養市場預測至 2030 年 - 區域分析 - 按營養類型和最終用戶

Middle East & Africa Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 84 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年中東及非洲腸外營養市場價值為2.0888億美元，預計2030年將達到2.8890億美元；預計2022年至2030年複合年成長率為4.1%。

營養產品配方創新支撐中東和非洲腸外營養市場

對幫助消費者主動管理健康的產品的需求激增，尤其是那些專注於能量水平、免疫力和疾病治療等特定需求的產品。營養需求因疾病類型而異。腸外產品的功能和特定配方不會干擾向患者提供的現有治療，並有助於根據要求提供更精確和增強的治療。腸外營養的常量營養素和微量營養素配方及其應用根據疾病類型（包括癌症和胃腸道疾病）而有所不同。

創新配方的重大發展帶來了營養解決方案的新時代，旨在滿足所有個人需求以及每位患者的醫療狀況。除了提高腸外營養的有效性之外，這種個人化程度還可以改善患者的治療效果。配方創新使市場能夠充分滿足不同患者的獨特營養需求，從新生兒、老年人到患有某些疾病的人。例如，穩定性和生物利用度提高的脂基乳劑的出現正在改變靜脈營養的面貌，特別是對於早產兒的治療。此外，由於這些配方創新，傳統上與傳統營養解決方案相關的問題和副作用的固有風險也降低了。該行業因其在醫療保健生態系統中促進腸外營養的採用和改善患者護理的雙重好處而有望實現非凡的成長和長期的成功。因此，營養產品配方的創新預計將為預測期內的市場成長創造機會。因此，營養產品配方的創新是腸外醫療營養市場未來的成長趨勢。

中東及非洲腸外營養市場概況

根據統計總局 2020 年年中的報告，沙烏地阿拉伯每年約有 25,000 名早產嬰兒。早產兒被放置在保溫箱中 30-60 天，政府醫院或保險公司可能會花費約 16,000 美元（60,000 沙烏地阿拉伯裡亞爾）用於個人治療和專門護理。如果需要將嬰兒保溫更長時間，可能會花費約 26,667 美元（100,000 沙烏地里亞爾）。在這種情況下，營養支持對於獲得與同齡嬰兒相似的生長速度至關重要，並且可以透過腸內或腸外方式提供。大多數未成熟的早產兒依賴腸外營養，特別是低出生體重（<1,500g）的嬰兒。由於與早產相關的嚴重醫療問題（例如主要器官發育不良、感染和餵食不耐受），此類嬰兒不接受腸內餵食。該國衛生部 (MoH) 經營 287 家醫院。根據衛生部公佈的資料，目前有 236 家醫院提供家庭醫療保健，其中一些醫院提供家庭腸內營養 (HEN) 或家庭腸外營養 (HPN) 服務，或兩者兼有。因此，由於早產數量不斷增加，以及政府加強支持和傳播民眾對腸外營養的認知，沙烏地阿拉伯對腸外營養的需求預計將迅速成長。

中東及非洲腸外營養市場收入及 2030 年預測（百萬美元）

中東和非洲腸外營養市場細分

中東和非洲腸外營養市場根據營養素類型、最終用戶和國家進行細分。根據營養類型，中東和非洲腸外營養市場分為單劑量胺基酸溶液、腸外脂肪乳、碳水化合物、微量元素以及維生素和礦物質。 2022 年，單劑量胺基酸溶液細分市場佔據最大市場佔有率。

依最終用戶分類，中東和非洲腸外營養市場分為醫院、診所等。 2022 年，醫院細分市場佔據最大的市場佔有率。

按國家/地區分類，中東和非洲腸外營養市場分為沙烏地阿拉伯、南非、阿拉伯聯合大公國以及中東和非洲其他地區。 2022 年，沙烏地阿拉伯在中東和非洲腸外營養市場佔有率中佔據主導地位。

ICU Medical Inc、Grifols SA、輝瑞公司、大塚製藥有限公司、百特國際公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是中東和非洲地區的一些領先參與者腸外營養市場。

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.

Significant developments in Innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care. Thus, innovation in the formulations of nutrition products is anticipated to create opportunities for the market growth during the forecast period. Thus, the innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.

Middle East & Africa Parenteral Nutrition Market Overview

According to a mid-2020 report from the General Authority for Statistics, ~25,000 babies are born prematurely in Saudi Arabia yearly. The premature babies are placed in incubators for 30-60 days, which can cost government hospitals or insurance companies ~US$ 16,000 (SAR 60,000) for individual treatment and specialized care. If babies are required to be kept in incubation for longer periods, it can cost ~US$ 26,667 (SAR 100,000). In such a scenario, nutritional support is crucial to attain a similar growth rate compared to babies of the same age, and it can be provided through enteral or parenteral ways. Most immature preterm babies depend on parenteral nutrition, especially for babies born with low birth weight (<1,500g). Such babies are not offered enteral feeding due to the severity of medical problems associated with prematurity (such as underdeveloped major organs, infections, and feeding intolerance). The Ministry of Health (MoH) in the country operates 287 hospitals. According to the data published by the MoH, 236 hospitals currently provide home healthcare, of which some either incorporate either home enteral nutrition (HEN) or home parenteral nutrition (HPN), or both services. Therefore, the demand for parenteral nutrition is anticipated to grow rapidly in Saudi Arabia due to the rising number of premature births and increasing government efforts to support and spread awareness among the population regarding parenteral nutrients.

Middle East & Africa Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Parenteral Nutrition Market Segmentation

The Middle East & Africa parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Middle East & Africa parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Middle East & Africa parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Middle East & Africa parenteral nutrition market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Middle East & Africa parenteral nutrition market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 Growing Healthcare Expenditure in Middle East & Africa Region
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - Middle East & Africa Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Middle East & Africa Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Parenteral Nutrition Market - Country Analysis

8.1 Middle East & Africa
- 8.1.1 Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 Saudi Arabia: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 Saudi Arabia: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 United Arab Emirates: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 United Arab Emirates: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 South Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 South Africa: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.4 Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.1 Overview
    - 8.1.1.4.2 Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.3 Rest of Middle East & Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.4.4 Rest of Middle East & Africa: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Vifor Pharma Management AG
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Parenteral Nutrition Market Segmentation
Table 2. Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 11. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Middle East & Africa: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)